Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Reutens AT, Jandeleit-Dahm K, Thomas M et al (2020) A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: protocol and statistical considerations
Iron entry in neurons and astrocytes: a link with synaptic activity
Prevention is better than aftercare
Preventing Chronic Disease, 20, E53
US$ 29.06
US$ 27.54
US$ 23.03
US$ 27.01
US$ 23.59
US$ 27.18
US$ 28.46
US$ 20.82
US$ 21.63
